Tvardi Therapeutics, Inc. TVRD
1.41 USD 0.00 (+0.00%)
At closeNov 10, 2026, 6:27 PM EST
1.42 +0.01 +0.71%
After hours · Nov 10, 6:27 PM ET
1.31 Day range 1.52
0.793 52-week range 5.00
- YTD
- -67.21%
- 1 year
- -66.35%
- Market cap
- 18.81M
- EPS (ttm)
- -2.88
- YTD return
- -67.21%
- 1-year return
- -66.35%
- Volume
- 550.12K
- Avg volume
- 234.15K
- Open
- 1.39
- Previous close
- 1.41
- Day's range
- 1.31 – 1.52
- 52-week range
- 0.793 – 5.00
5D +0.47 (+54.73%)
Financials — quick view
TVRD Revenue — quarterly 0
TVRD Net income — quarterly -6.46M
TVRD EPS — quarterly -0.69
News
12 Health Care Stocks Moving In Monday's After-Market Session 
Chardan Capital Initiates Coverage On Tvardi Therapeutics with Buy Rating, Announces Price Target of $8 
Tvardi Therapeutics to Participate in Chardan's 10th Annual Healthcare Conference 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
Head-To-Head Survey: Tvardi Therapeutics (NASDAQ:TVRD) versus Phibro Animal Health (NASDAQ:PAHC) 
12 Health Care Stocks Moving In Wednesday's After-Market Session - 12 Health Care Stocks Moving In Thursday's Intraday Session
Tvardi Therapeutics Announces Publication Of Preclinical Data Evaluating Its STAT3 Inhibitor In International Journal Of Molecular Sciences 
New Preclinical Data Further Support Potential for Tvardi's STAT3 Inhibitors in Ulcerative Colitis (UC) 
Tvardi Therapeutics to Participate in Upcoming Investor Events
Your note
Sign in to keep a note on TVRD — it syncs with the Stock Master app.